Аннотация
22 patients (mean age 45.08 ± 1.38 years) with essential hypertension stage II were entered in a placebo-controlled blind trial of cilazapril, angiotensin-converting enzyme. A complex of clinical-instrumental tests comprised dipidamol test, bicycle ergometry, 199Tl myocardial scintigraphy, echo-CG. A 3-month course of cilazapril reduced myocardial hypoperfusion in 15 patients, improved left ventricular relaxation. Antiischemia effect of the drug was also evident.
Язык оригинала | Английский |
---|---|
Страницы (с-по) | 50-53 |
Число страниц | 4 |
Журнал | Terapevticheskii Arkhiv |
Том | 67 |
Номер выпуска | 9 |
Состояние | Опубликовано - 1995 |
Опубликовано для внешнего пользования | Да |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism